PH25545A - Sustained release multi-granule tablet - Google Patents

Sustained release multi-granule tablet

Info

Publication number
PH25545A
PH25545A PH35625A PH35625A PH25545A PH 25545 A PH25545 A PH 25545A PH 35625 A PH35625 A PH 35625A PH 35625 A PH35625 A PH 35625A PH 25545 A PH25545 A PH 25545A
Authority
PH
Philippines
Prior art keywords
sustained release
tablet
formulation adjuvant
release multi
sustained
Prior art date
Application number
PH35625A
Other languages
English (en)
Inventor
Hidenobu Andoh
Sumio Watanabe
Yasuo Muyake
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of PH25545A publication Critical patent/PH25545A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Vending Machines For Individual Products (AREA)
  • Mechanical Pencils And Projecting And Retracting Systems Therefor, And Multi-System Writing Instruments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH35625A 1986-08-06 1987-08-05 Sustained release multi-granule tablet PH25545A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61183414A JPH0780754B2 (ja) 1986-08-06 1986-08-06 多顆粒型持続性錠剤

Publications (1)

Publication Number Publication Date
PH25545A true PH25545A (en) 1991-08-08

Family

ID=16135361

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35625A PH25545A (en) 1986-08-06 1987-08-05 Sustained release multi-granule tablet

Country Status (11)

Country Link
EP (1) EP0255725B1 (de)
JP (1) JPH0780754B2 (de)
KR (1) KR950002148B1 (de)
AT (1) ATE102480T1 (de)
CA (1) CA1315680C (de)
DE (1) DE3789258T2 (de)
DK (1) DK175798B1 (de)
ES (1) ES2050653T3 (de)
FI (1) FI96480C (de)
NO (1) NO178134C (de)
PH (1) PH25545A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
DE4122217C2 (de) * 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
ATE219931T1 (de) * 1993-10-12 2002-07-15 Mitsubishi Pharma Corp Darmlösliche grannulatkörner enthaltende tablette
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
FR2795962B1 (fr) 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
EP1339395A2 (de) 2000-11-28 2003-09-03 Fmc Corporation Essbare überzugszusammensetzung aus pga (propylenglykolalginat)
MXPA03000985A (es) 2001-07-27 2004-04-02 Yamanouchi Pharma Co Ltd Composicion que comprende particulas finas de liberacion sostenida para tabletas de desintegracion rapida en la cavidad bucal y metodo de fabricacion de la misma.
FR2837100B1 (fr) 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1390032A (en) * 1971-08-27 1975-04-09 Sterling Winthrop Group Ltd Pharmaceutical compositions
JPS5873359A (ja) * 1981-10-27 1983-05-02 旭化成株式会社 医薬錠剤の製造方法

Also Published As

Publication number Publication date
EP0255725A3 (de) 1991-01-30
DK407287D0 (da) 1987-08-05
NO178134C (no) 1996-01-31
FI96480B (fi) 1996-03-29
ES2050653T3 (es) 1994-06-01
JPS6339811A (ja) 1988-02-20
KR950002148B1 (ko) 1995-03-14
KR880002510A (ko) 1988-05-09
ATE102480T1 (de) 1994-03-15
DE3789258D1 (de) 1994-04-14
FI873407A0 (fi) 1987-08-05
NO873273D0 (no) 1987-08-05
EP0255725A2 (de) 1988-02-10
JPH0780754B2 (ja) 1995-08-30
FI873407L (fi) 1988-02-07
DE3789258T2 (de) 1994-08-11
NO873273L (no) 1988-02-08
EP0255725B1 (de) 1994-03-09
DK407287A (da) 1988-02-07
CA1315680C (en) 1993-04-06
NO178134B (no) 1995-10-23
DK175798B1 (da) 2005-02-28
FI96480C (fi) 1996-07-10

Similar Documents

Publication Publication Date Title
IL88083A (en) Controlled release pharmaceutical dosage form and its preparation
SE8504720D0 (sv) New drug preparation
ATE100708T1 (de) Unbeschichtete pharmazeutische reaktionstablette.
FI883785A7 (fi) Kapseli lääkeaineen farmaseuttisesti vaikuttavaa inhalointiainetta varten.
JPS649930A (en) Device for drug control release
DE3776982D1 (de) Arzneimittel mit gesteuerter absorption.
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
CA2024502A1 (en) Dosage form for administering oral hypoglycemic glipizide
NO871277D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler.
FI885460L (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
ATE44130T1 (de) Pharmazeutische produkte mit einem gehalt an magnesiumtrisilikat-adsorbens mit darauf adsorbiertem heilmittelwirkstoff.
DE3789258D1 (de) Multigranuläre Tablette mit verzögerter Freisetzung.
NO882406D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser.
GEP19991686B (en) Pharmaceutical Composition for Obtaining Effervescent Powder or Tablet, Pharmaceutical Preparation and Method for Preparing Same
NO865195L (no) FremgangsmŸte for fremstilling av et retardpreparat av ibuprofen.
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
SE8505569D0 (sv) Enteralt preparat
EP0425298A3 (en) Sustained-release preparation of basic medical agent hydrochloride
EP0019403A3 (en) Hydroxyalkyl-starch drug carrier and method of administering a biologically active compound to an animal
DE68905613D1 (de) Pharmazeutische zubereitung.
JPS6463521A (en) Trapidyl-containing drug composition, manufacture and related therapeutical use
GB1379008A (en) Medicament for the treatment of herpes simplex
AU2366388A (en) A method for the preparation of a pharmaceutical curative for the veterinary and humane medicine, with antiviral and antitumoral effect
NO873805D0 (no) Medisinsk doseringsanordning for uttoemning av forstoevet medikament for inhaleringsluft.
MY102184A (en) New drug preparation with controlled release of the active compound, a method for the manufacture thereof and the use of the new preparation